4//SEC Filing
Bonello William 4
Accession 0001077183-21-000254
CIK 0001077183other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 6:09 PM ET
Size
12.4 KB
Accession
0001077183-21-000254
Insider Transaction Report
Form 4
Bonello William
VP, Investor Relations
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-11-30−25,000→ 10,727 totalExercise: $7.52Exp: 2022-04-28→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2021-11-30$7.52/sh+25,000$188,000→ 40,473 total
Holdings
- 37,514
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying) - 45,370
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (45,370 underlying) - 41,167
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (41,167 underlying) - 24,619
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (24,619 underlying)
Footnotes (5)
- [F1]On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F2]On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date
- [F4]On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001454941
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 6:09 PM ET
- Size
- 12.4 KB